ArticleJournal of hematology & oncology2023

Novel agents and evolving strategies in myelofibrotive neoplasm: an update from 2022 ASH annual conference.

Andrew Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.